Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Mining Occupational Safety and Health Research (R01), Request for Application (RFA) OH08-003, 18536 [E8-7033]
Download as PDF
18536
Federal Register / Vol. 73, No. 66 / Friday, April 4, 2008 / Notices
ebenthall on PRODPC61 with NOTICES
evaluation process. Relevant data
received after this date will be
considered during the ICCVAM
evaluation process, if feasible. All
information submitted in response to
this notice will be made publicly
available and may be incorporated into
future NICEATM and ICCVAM reports
and publications as appropriate.
When submitting data, please
reference this Federal Register notice
and provide appropriate contact
information (name, affiliation, mailing
address, phone, fax, e-mail, and
sponsoring organization, as applicable).
NICEATM prefers that data be
submitted as copies of pages from study
notebooks and/or study reports, if
available. Raw data and analyses
available in electronic format may also
be submitted. Each submission for a
substance should preferably include the
following information, as appropriate:
• Common and trade name
• Chemical Abstracts Service Registry
Number (CASRN)
• Chemical and/or product class
• Commercial source
• In vivo or in vitro test protocol used
• Individual animal or in vitro
responses at each observation time (i.e.,
raw data)
• The extent to which the study
complied with national/international
Good Laboratory Practice (GLP)
guidelines
• Date and testing organization
• Physical and chemical properties
(e.g. molecular weight, pH, water
solubility, etc.)
Background Information on ICCVAM
and NICEATM
ICCVAM is an interagency committee
composed of representatives from 15
Federal regulatory and research agencies
that use or generate toxicological
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative methods with regulatory
applicability and promotes the scientific
validation and regulatory acceptance of
toxicological test methods that more
accurately assess the safety and hazards
of chemicals and products and that
refine, reduce, and replace animal use.
The ICCVAM Authorization Act of 2000
(42 U.S.C. 2851–3, available at (https://
iccvam.niehs.nih.gov/docs/about_docs/
PL106545.pdf) established ICCVAM as a
permanent interagency committee of the
NIEHS under NICEATM. NICEATM
administers ICCVAM and provides
scientific and operational support for
ICCVAM-related activities. NICEATM
and ICCVAM work collaboratively to
evaluate new and improved test
methods applicable to the needs of
Federal agencies. Additional
VerDate Aug<31>2005
15:24 Apr 03, 2008
Jkt 214001
information about ICCVAM and
NICEATM is available on the following
Web site: https://iccvam.niehs.nih.gov.
Dated: March 24, 2008.
Samuel H. Wilson,
Acting Director, National Institute of
Environmental Health Sciences and National
Toxicology Program.
[FR Doc. E8–6969 Filed 4–3–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Identification,
Surveillance and Control of VectorBorne and Zoonotic Infectious
Diseases in Uganda, Funding
Opportunity Announcement (FOA)
CK08–004
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12 p.m.–2 p.m., May
16, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Identification,
Surveillance and Control of VectorBorne and Zoonotic Infectious Diseases
in Uganda,’’ FOA CK08–004.
Contact Person for More Information:
Shoukat Qari, D.V.M., PhD, Scientific
Review Administrator, Strategic Science
and Program Unit, Office of the Director,
Coordinating Center for Infectious
Diseases, CDC, 1600 Clifton Road,
Mailstop C–19, Atlanta, GA, Telephone
(404) 639–8942.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Dated: March 28, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–7032 Filed 4–3–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Mining
Occupational Safety and Health
Research (R01), Request for
Application (RFA) OH08–003
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates: 5 p.m.–7 p.m., May
7, 2008 (Closed). 8 a.m.–5 p.m., May 8,
2008 (Closed). 8 a.m.–5 p.m., May 9,
2008 (Closed).
Place: Radisson Plaza-Warwick Hotel
Philadelphia, 1701 Locust Street #411,
Philadelphia, PA 19103.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Mining Occupational
Safety and Health Research (R01), RFA
OH08–003.’’
Contact Person for More Information:
Charles N. Rafferty, PhD, Assistant
Director for Review and Policy Office of
Extramural Programs, CDC, 1600 Clifton
Road, NE., Mailstop E74, Atlanta, GA
30333, Telephone: (404) 498–2530.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: March 28, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–7033 Filed 4–3–08; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 73, Number 66 (Friday, April 4, 2008)]
[Notices]
[Page 18536]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-7033]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control; Special
Emphasis Panel (SEP): Mining Occupational Safety and Health Research
(R01), Request for Application (RFA) OH08-003
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Times and Dates: 5 p.m.-7 p.m., May 7, 2008 (Closed). 8 a.m.-5
p.m., May 8, 2008 (Closed). 8 a.m.-5 p.m., May 9, 2008 (Closed).
Place: Radisson Plaza-Warwick Hotel Philadelphia, 1701 Locust
Street 411, Philadelphia, PA 19103.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of ``Mining Occupational Safety and Health
Research (R01), RFA OH08-003.''
Contact Person for More Information: Charles N. Rafferty, PhD,
Assistant Director for Review and Policy Office of Extramural Programs,
CDC, 1600 Clifton Road, NE., Mailstop E74, Atlanta, GA 30333,
Telephone: (404) 498-2530.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: March 28, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-7033 Filed 4-3-08; 8:45 am]
BILLING CODE 4163-18-P